Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair.  It offers a spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care and skin rejuvenation. The company's proprietary technology is based on hyaluronic acid, a naturally occurring polymer found throughout the body vital for proper joint health and tissue function. Its products include MONOVISC, ORTHOVISC, and ORTHOVISC mini used in the treatment of osteoarthritis; HYVISC used in the treatment of equine osteoarthritis; ELEVESS cosmetic dermal filler with lidocaine; ANIKAVISC viscoelastic for ophthalmic surgery; INCERT-S anti-adhesion surgical gel; and next generation products for joint health, advanced wound care, and other applications.